New medicine reduced risk for heart failure emergencies, hospital visits

(American Heart Association) Results from a large, Phase 3, global, cardiovascular outcomes study indicate a new medication may reduce the risk for heart failure-related events or cardiovascular deaths in people with chronic heart failure.